Although the positive rates of PGP9.5, SOX2 and combined detection were significantly different among the three groups (p < 0.05), 7‐TAAbs were not suitable for the initial screening of LC in patients with micro pulmonary nodules, in view of their low sensitivity. The gene discussed is SOX2; the disease is laryngotracheoesophageal cleft.